Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine Efficacy for P. Vivax Radical Cure
NCT04706130Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Apr 2021
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of primaquine in vivax malaria (3 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Number of Patients Experiencing P. Vivax Recurrence at 3 months. Started Apr 2021; status: completed.
02
Drugs
primaquine
03
Conditions
vivax malaria
Beyond the preview
Go deeper on NCT04706130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04706130.